RNA interference is a biological process in which RNA molecules inhibit gene expression or translation, by neutralizing targeted mRNA molecules. Historically, RNAi was known by other names, including co-suppression, post-transcriptional gene silencing, and quelling.
The RNA-interference (RNAi) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the RNA-interference (RNAi) industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The RNA-interference (RNAi) market can be split based on product types, major applications, and important countries as follows:
Key players in the global RNA-interference (RNAi) market covered in Chapter 12:
Tekmira Pharmaceuticals Corporation
Phio Pharmaceuticals Corp.
Quark Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc.
Dicerna Pharmaceuticals
Silence Therapeutics PLC
Qiagen NV
Arrowhead
Merck & Co. Inc. (Sigma Aldrich)
ISIS Pharmaceuticals
Alnylam Pharmaceuticals
Thermo Fisher Scientific Inc.
Benitec Biopharma Ltd
Arcturus Therapeutics
RXI Pharmaceuticals
In Chapter 4 and 14.1, on the basis of types, the RNA-interference (RNAi) market from 2015 to 2025 is primarily split into:
Chemical synthesis
In vitro transcription
In vivo expression
In Chapter 5 and 14.2, on the basis of applications, the RNA-interference (RNAi) market from 2015 to 2025 covers:
Drug Discovery and Development
Therapeutics
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 RNA-interference (RNAi) Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of RNA-interference (RNAi)
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the RNA-interference (RNAi) industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global RNA-interference (RNAi) Market Size, 2015 - 2020
2.1.2 Global RNA-interference (RNAi) Market Size by Type, 2015 - 2020
2.1.3 Global RNA-interference (RNAi) Market Size by Application, 2015 - 2020
2.1.4 Global RNA-interference (RNAi) Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on RNA-interference (RNAi) Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of RNA-interference (RNAi) Analysis
3.2 Major Players of RNA-interference (RNAi)
3.3 RNA-interference (RNAi) Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of RNA-interference (RNAi)
3.3.3 Labor Cost of RNA-interference (RNAi)
3.4 Market Distributors of RNA-interference (RNAi)
3.5 Major Downstream Buyers of RNA-interference (RNAi) Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global RNA-interference (RNAi) Market, by Type
4.1 Global RNA-interference (RNAi) Value and Market Share by Type (2015-2020)
4.2 Global RNA-interference (RNAi) Production and Market Share by Type (2015-2020)
4.3 Global RNA-interference (RNAi) Value and Growth Rate by Type (2015-2020)
4.3.1 Global RNA-interference (RNAi) Value and Growth Rate of Chemical synthesis
4.3.2 Global RNA-interference (RNAi) Value and Growth Rate of In vitro transcription
4.3.3 Global RNA-interference (RNAi) Value and Growth Rate of In vivo expression
4.4 Global RNA-interference (RNAi) Price Analysis by Type (2015-2020)
5 RNA-interference (RNAi) Market, by Application
5.1 Downstream Market Overview
5.2 Global RNA-interference (RNAi) Consumption and Market Share by Application (2015-2020)
5.3 Global RNA-interference (RNAi) Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global RNA-interference (RNAi) Consumption and Growth Rate of Drug Discovery and Development (2015-2020)
5.3.2 Global RNA-interference (RNAi) Consumption and Growth Rate of Therapeutics (2015-2020)
6 Global RNA-interference (RNAi) Market Analysis by Regions
6.1 Global RNA-interference (RNAi) Sales, Revenue and Market Share by Regions
6.1.1 Global RNA-interference (RNAi) Sales by Regions (2015-2020)
6.1.2 Global RNA-interference (RNAi) Revenue by Regions (2015-2020)
6.2 North America RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
6.3 Europe RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
6.6 South America RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
7 North America RNA-interference (RNAi) Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America RNA-interference (RNAi) Sales, Revenue and Market Share by Countries
7.2.1 North America RNA-interference (RNAi) Sales by Countries (2015-2020)
7.2.2 North America RNA-interference (RNAi) Revenue by Countries (2015-2020)
7.3 United States RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
7.4 Canada RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
7.5 Mexico RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
8 Europe RNA-interference (RNAi) Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe RNA-interference (RNAi) Sales, Revenue and Market Share by Countries
8.2.1 Europe RNA-interference (RNAi) Sales by Countries (2015-2020)
8.2.2 Europe RNA-interference (RNAi) Revenue by Countries (2015-2020)
8.3 Germany RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
8.4 UK RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
8.5 France RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
8.6 Italy RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
8.7 Spain RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
8.8 Russia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
9 Asia Pacific RNA-interference (RNAi) Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific RNA-interference (RNAi) Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific RNA-interference (RNAi) Sales by Countries (2015-2020)
9.2.2 Asia Pacific RNA-interference (RNAi) Revenue by Countries (2015-2020)
9.3 China RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
9.4 Japan RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
9.5 South Korea RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
9.6 India RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
9.7 Southeast Asia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
9.8 Australia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
10 Middle East and Africa RNA-interference (RNAi) Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa RNA-interference (RNAi) Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa RNA-interference (RNAi) Sales by Countries (2015-2020)
10.2.2 Middle East and Africa RNA-interference (RNAi) Revenue by Countries (2015-2020)
10.3 Saudi Arabia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
10.4 UAE RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
10.5 Egypt RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
10.6 Nigeria RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
10.7 South Africa RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
11 South America RNA-interference (RNAi) Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America RNA-interference (RNAi) Sales, Revenue and Market Share by Countries
11.2.1 South America RNA-interference (RNAi) Sales by Countries (2015-2020)
11.2.2 South America RNA-interference (RNAi) Revenue by Countries (2015-2020)
11.3 Brazil RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
11.4 Argentina RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
11.5 Columbia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
11.6 Chile RNA-interference (RNAi) Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Tekmira Pharmaceuticals Corporation
12.1.1 Tekmira Pharmaceuticals Corporation Basic Information
12.1.2 RNA-interference (RNAi) Product Introduction
12.1.3 Tekmira Pharmaceuticals Corporation Production, Value, Price, Gross Margin 2015-2020
12.2 Phio Pharmaceuticals Corp.
12.2.1 Phio Pharmaceuticals Corp. Basic Information
12.2.2 RNA-interference (RNAi) Product Introduction
12.2.3 Phio Pharmaceuticals Corp. Production, Value, Price, Gross Margin 2015-2020
12.3 Quark Pharmaceuticals Inc.
12.3.1 Quark Pharmaceuticals Inc. Basic Information
12.3.2 RNA-interference (RNAi) Product Introduction
12.3.3 Quark Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
12.4 Ionis Pharmaceuticals Inc.
12.4.1 Ionis Pharmaceuticals Inc. Basic Information
12.4.2 RNA-interference (RNAi) Product Introduction
12.4.3 Ionis Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
12.5 Dicerna Pharmaceuticals
12.5.1 Dicerna Pharmaceuticals Basic Information
12.5.2 RNA-interference (RNAi) Product Introduction
12.5.3 Dicerna Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.6 Silence Therapeutics PLC
12.6.1 Silence Therapeutics PLC Basic Information
12.6.2 RNA-interference (RNAi) Product Introduction
12.6.3 Silence Therapeutics PLC Production, Value, Price, Gross Margin 2015-2020
12.7 Qiagen NV
12.7.1 Qiagen NV Basic Information
12.7.2 RNA-interference (RNAi) Product Introduction
12.7.3 Qiagen NV Production, Value, Price, Gross Margin 2015-2020
12.8 Arrowhead
12.8.1 Arrowhead Basic Information
12.8.2 RNA-interference (RNAi) Product Introduction
12.8.3 Arrowhead Production, Value, Price, Gross Margin 2015-2020
12.9 Merck & Co. Inc. (Sigma Aldrich)
12.9.1 Merck & Co. Inc. (Sigma Aldrich) Basic Information
12.9.2 RNA-interference (RNAi) Product Introduction
12.9.3 Merck & Co. Inc. (Sigma Aldrich) Production, Value, Price, Gross Margin 2015-2020
12.10 ISIS Pharmaceuticals
12.10.1 ISIS Pharmaceuticals Basic Information
12.10.2 RNA-interference (RNAi) Product Introduction
12.10.3 ISIS Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.11 Alnylam Pharmaceuticals
12.11.1 Alnylam Pharmaceuticals Basic Information
12.11.2 RNA-interference (RNAi) Product Introduction
12.11.3 Alnylam Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.12 Thermo Fisher Scientific Inc.
12.12.1 Thermo Fisher Scientific Inc. Basic Information
12.12.2 RNA-interference (RNAi) Product Introduction
12.12.3 Thermo Fisher Scientific Inc. Production, Value, Price, Gross Margin 2015-2020
12.13 Benitec Biopharma Ltd
12.13.1 Benitec Biopharma Ltd Basic Information
12.13.2 RNA-interference (RNAi) Product Introduction
12.13.3 Benitec Biopharma Ltd Production, Value, Price, Gross Margin 2015-2020
12.14 Arcturus Therapeutics
12.14.1 Arcturus Therapeutics Basic Information
12.14.2 RNA-interference (RNAi) Product Introduction
12.14.3 Arcturus Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.15 RXI Pharmaceuticals
12.15.1 RXI Pharmaceuticals Basic Information
12.15.2 RNA-interference (RNAi) Product Introduction
12.15.3 RXI Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global RNA-interference (RNAi) Market Forecast
14.1 Global RNA-interference (RNAi) Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Chemical synthesis Market Value and Volume Forecast (2020-2025)
14.1.2 In vitro transcription Market Value and Volume Forecast (2020-2025)
14.1.3 In vivo expression Market Value and Volume Forecast (2020-2025)
14.2 Global RNA-interference (RNAi) Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Drug Discovery and Development Market Value and Volume Forecast (2020-2025)
14.2.2 Therapeutics Market Value and Volume Forecast (2020-2025)
14.3 RNA-interference (RNAi) Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter
Global Personal Car Leasing Market Resea..
The report focuses on the Personal Car Leasing market size, ..
+16467917070US (Toll Free)